These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15905712

  • 1. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
    Kamm MA.
    Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE, Hanauer SB.
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
    Bauer WM, Brzezinski A, Lashner BA.
    Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.
    Feagan BG.
    Clin Gastroenterol Hepatol; 2004 May; 2(5):376-8. PubMed ID: 15118974
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG.
    Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
    [No Abstract] [Full Text] [Related]

  • 10. [Improved treatment of Crohn's disease].
    Nau JY.
    Rev Med Suisse; 2005 May 04; 1(18):1241. PubMed ID: 15977716
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mesalamine maintenance therapy for Crohn's disease.
    Feagan BG, McDonald JW.
    Gastroenterology; 2001 Feb 04; 120(2):585-6. PubMed ID: 11271451
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.
    Cammà C, Giunta M, Rosselli M, Cottone M.
    Gastroenterology; 1997 Nov 04; 113(5):1465-73. PubMed ID: 9352848
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of circulating platelet derived microparticles in Crohn's disease patients.
    Tziatzios G, Polymeros D, Spathis A, Triantafyllou M, Gkolfakis P, Karakitsos P, Dimitriadis G, Triantafyllou K.
    Scand J Gastroenterol; 2016 Oct 04; 51(10):1184-92. PubMed ID: 27191369
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.